α4β7 Integrin Antagonist Vedolizumab for the Treatment of Refractory Ileitis

Figure 1

Representative endoscopy images: (a). Initial ileoscopy showing erythematous, edematous friable mucosa with the presence of spontaneous bleeding. (b). Follow-up ileoscopy demonstrating normal looking mucosa after 5 months of vedolizumab therapy.

(a)

(b)